Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic therapy for Alzheimer's disease patients
2015-002965-43Phase 2Completed
- Sponsor
- Fondazione Santa Lucia IRCCS
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of rotigotine in Alzheimer's disease (AD), sponsored by Fondazione Santa Lucia IRCCS. Primary endpoints: Positive effects on general cognitive functions and Positive effects on frontal executive functions. Started Feb 2018; status: completed.
02
Drugs
rotigotine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2015-002965-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002965-43.